Compare LMFA & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LMFA | SPRC |
|---|---|---|
| Founded | 2008 | 2004 |
| Country | United States | Israel |
| Employees | 19 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 3.3M |
| IPO Year | 2015 | 2014 |
| Metric | LMFA | SPRC |
|---|---|---|
| Price | $2.60 | $4.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 35.2K |
| Earning Date | 05-15-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.66 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,844,733.00 | N/A |
| Revenue This Year | $4.38 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.12 | $0.46 |
| 52 Week High | $4.75 | $15.79 |
| Indicator | LMFA | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 81.13 | 40.73 |
| Support Level | $0.24 | $4.12 |
| Resistance Level | $3.40 | $4.85 |
| Average True Range (ATR) | 0.18 | 0.54 |
| MACD | 0.22 | 0.02 |
| Stochastic Oscillator | 77.43 | 34.31 |
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining and Treasury Operations.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.